YU324780A - Process for preparing 2-acylaminoethyl-1,4-benzo diazepines - Google Patents

Process for preparing 2-acylaminoethyl-1,4-benzo diazepines

Info

Publication number
YU324780A
YU324780A YU03247/80A YU324780A YU324780A YU 324780 A YU324780 A YU 324780A YU 03247/80 A YU03247/80 A YU 03247/80A YU 324780 A YU324780 A YU 324780A YU 324780 A YU324780 A YU 324780A
Authority
YU
Yugoslavia
Prior art keywords
acylaminoethyl
preparing
diazepines
benzo
benzo diazepines
Prior art date
Application number
YU03247/80A
Other languages
English (en)
Inventor
H Zeugner
D Roemer
H Liepmann
W Milkowski
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of YU324780A publication Critical patent/YU324780A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D245/06—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YU03247/80A 1979-12-24 1980-12-22 Process for preparing 2-acylaminoethyl-1,4-benzo diazepines YU324780A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792952279 DE2952279A1 (de) 1979-12-24 1979-12-24 Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
YU324780A true YU324780A (en) 1983-12-31

Family

ID=6089628

Family Applications (1)

Application Number Title Priority Date Filing Date
YU03247/80A YU324780A (en) 1979-12-24 1980-12-22 Process for preparing 2-acylaminoethyl-1,4-benzo diazepines

Country Status (21)

Country Link
US (2) US4325957A (el)
EP (1) EP0031080B1 (el)
JP (1) JPS5699477A (el)
AU (1) AU542701B2 (el)
CA (1) CA1169425A (el)
DD (2) DD200274A5 (el)
DE (3) DE2952279A1 (el)
DK (1) DK548080A (el)
ES (2) ES498072A0 (el)
FI (1) FI68050C (el)
GR (1) GR73080B (el)
HU (1) HU185398B (el)
IE (1) IE50580B1 (el)
IL (1) IL61692A (el)
NO (1) NO154883C (el)
NZ (1) NZ195872A (el)
PH (1) PH17189A (el)
PT (2) PT72279B (el)
SU (1) SU1253430A3 (el)
YU (1) YU324780A (el)
ZA (1) ZA807704B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3021107A1 (de) * 1980-06-04 1981-12-17 Hoechst Ag, 6000 Frankfurt Carbamoyloxyamino-1,4-benzodiazepine, verfahren zu irer herstellung und diese enthaltende arzneimittel
DE3048264A1 (de) * 1980-12-20 1982-09-09 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3124013A1 (de) * 1981-06-19 1982-12-30 Kali-Chemie Pharma Gmbh, 3000 Hannover 2-acylaminomethyl-1,4-benzodiazepin-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3151597A1 (de) * 1981-12-28 1983-07-07 Kali-Chemie Pharma Gmbh, 3000 Hannover (1,2)-anellierte 1,4-benzodiazepin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0170024A3 (en) * 1984-06-26 1990-01-31 Merck & Co. Inc. Use of 2-acylaminomethyl-1,4-benzodiazepine derivatives for the production of pharmaceutical compositions and process for the preparation for pharmaceutical compositions
US4684646A (en) * 1984-06-26 1987-08-04 Merck & Co., Inc. 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists
US4724237A (en) * 1984-06-26 1988-02-09 Merck & Co., Inc. 2-substituted-aminomethyl-1,4-benzodiazepines
JPH01314666A (ja) * 1988-06-15 1989-12-19 Kayaba Ind Co Ltd パワーステアリング装置の操舵力制御装置
GB8823042D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
US5380721A (en) * 1990-09-10 1995-01-10 Sterling Winthrop Inc. Aryl-fused and hetaryl-fused-2,4-diazepine and 2,4-diazocine antiarrhythmic agents
JPH0546660U (ja) * 1991-12-03 1993-06-22 カヤバ工業株式会社 パワーステアリング装置
AU6935500A (en) 1999-08-27 2001-03-26 Procter & Gamble Company, The Stability enhancing formulation components, compositions and laundry methods employing same
US6821935B1 (en) 1999-08-27 2004-11-23 Procter & Gamble Company Color safe laundry methods employing zwitterionic formulation components
US6818607B1 (en) 1999-08-27 2004-11-16 Procter & Gamble Company Bleach boosting components, compositions and laundry methods
US6903060B1 (en) 1999-08-27 2005-06-07 Procter & Gamble Company Stable formulation components, compositions and laundry methods employing same
US7109156B1 (en) 1999-08-27 2006-09-19 Procter & Gamble Company Controlled availability of formulation components, compositions and laundry methods employing same
CZ2002720A3 (cs) * 1999-08-27 2002-09-11 The Procter & Gamble Company Složky zesilující bělení, prostředky a způsoby praní s využitím složek zesilujících bělení
MXPA02002129A (es) * 1999-08-27 2002-09-18 Procter & Gamble Componentes de formulacion de accion rapida, composiciones y metodos para lavanderia que los emplean.
US6825160B1 (en) 1999-08-27 2004-11-30 Procter & Gamble Company Color safe laundry methods employing cationic formulation components
US7557076B2 (en) * 2002-06-06 2009-07-07 The Procter & Gamble Company Organic catalyst with enhanced enzyme compatibility
US7169744B2 (en) 2002-06-06 2007-01-30 Procter & Gamble Company Organic catalyst with enhanced solubility
US20050113246A1 (en) * 2003-11-06 2005-05-26 The Procter & Gamble Company Process of producing an organic catalyst
AR051659A1 (es) * 2005-06-17 2007-01-31 Procter & Gamble Una composicion que comprende un catalizador organico con compatibilidada enzimatica mejorada
KR100877824B1 (ko) 2005-11-11 2009-01-12 한국생명공학연구원 Ｅ2ｅｐｆ ｕｃｐ-ｖｈｌ 상호작용 및 그 용도
CN113149914A (zh) * 2021-01-15 2021-07-23 福安药业集团重庆礼邦药物开发有限公司 一种咪达唑仑中间体脱氟杂质的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681340A (en) * 1968-02-12 1972-08-01 Herman Robert Rodriguez 1,3-benzodiazepines
US3738999A (en) * 1970-05-28 1973-06-12 Squibb & Sons Inc 2,3,4,5-tetrahydro-2-phenyl-1,4-benzothiazepine, hydrochloride
DE2353187A1 (de) * 1973-05-02 1974-11-14 Kali Chemie Ag Neue benzodiazepinderivate
DE2353160C2 (de) * 1973-05-02 1986-07-17 Kali-Chemie Ag, 3000 Hannover 5-Phenyl-2,3-dihydro-1H-1,4-benzodiazepine, ihre Säureadditionssalze und diese Verbindungen enthaltende Arzneimittel
US3925358A (en) * 1973-07-27 1975-12-09 Hoffmann La Roche 1-Lower alkyl-2-substituted-1,4-benzodiazepines
US3947475A (en) * 1975-04-28 1976-03-30 Stauffer Chemical Company 5-Furoyl-2,2,4-trimethyl-1,4-dihydro-1H-1,5-benzodiazepine as an anti-inflammatory agent
US4087421A (en) * 1976-04-19 1978-05-02 American Cyanamid Company Substituted benzodiazepines and method of use

Also Published As

Publication number Publication date
NO154883C (no) 1987-01-07
PT72279A (en) 1981-01-01
DD155988A5 (de) 1982-07-21
ES8201143A1 (es) 1981-12-01
NZ195872A (en) 1983-06-17
DD200274A5 (de) 1983-04-06
DK548080A (da) 1981-07-23
JPS6332072B2 (el) 1988-06-28
NO803935L (no) 1981-06-25
SU1253430A3 (ru) 1986-08-23
FI68050B (fi) 1985-03-29
US4325957A (en) 1982-04-20
ES8201142A1 (es) 1981-12-01
AU542701B2 (en) 1985-03-07
GR73080B (el) 1984-01-31
ES498072A0 (es) 1981-12-01
NO154883B (no) 1986-09-29
HU185398B (en) 1985-01-28
CA1169425A (en) 1984-06-19
ES498071A0 (es) 1981-12-01
JPS5699477A (en) 1981-08-10
IL61692A0 (en) 1981-01-30
DE3064983D1 (en) 1983-10-27
EP0031080B1 (de) 1983-09-21
EP0031080A1 (de) 1981-07-01
PH17189A (en) 1984-06-14
IE802531L (en) 1981-06-24
DE2952279A1 (de) 1981-06-25
FI68050C (fi) 1985-07-10
PT72279B (en) 1981-11-06
IL61692A (en) 1984-08-31
PT72278A (en) 1981-01-01
ZA807704B (en) 1981-11-25
US4382030A (en) 1983-05-03
IE50580B1 (en) 1986-05-14
PT72278B (en) 1981-11-06
DE3070798D1 (en) 1985-07-25
FI803988L (fi) 1981-06-25
AU6566480A (en) 1981-07-02

Similar Documents

Publication Publication Date Title
YU324780A (en) Process for preparing 2-acylaminoethyl-1,4-benzo diazepines
YU289180A (en) Process for preparing alfa-aryl-1h-1,2,4-triazole-1-ethanols
YU43116B (en) Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
HU182185B (en) Process for preparing 5-substituted 2,3-diaryl-thiophene derivatives
GB2058075B (en) Process for preparing 1a-hydroxyvitamin d compounds from 1a-hydroxy-3,5-cyclovitamin d compounds
PT71404B (en) Process for preparing 2,3-dihydro-2,6,7-trisubstituted-5-acylbenzofurans
YU41747B (en) Process for obtaining 6alpha fluoro-9-alpha-chloro-predisolone-17,21-disters
PT70770A (en) Process for selectively preparing isosorbide-5-nitrate
PT71952B (en) Process for preparing 3,6,7,8-substituted-s-triazolo-^4,3-b[- pyridazines
DE3070919D1 (en) Process for preparing 1,3,7-trialkylxanthines
GB2055825B (en) Process for producing 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
DE3061037D1 (en) Process for preparing dimethylaminosilanes
YU298779A (en) Process for preparing 2,6-dialkyl-n-alkoxymethyl-2-chloroacetanilides
DE3060089D1 (en) Process for preparing 1-amino-2-phenoxy-4-hydroxy-anthraquinone
PT72111A (en) Process for preparing 3-hydroxymethyldibenzo-/b,f/thiepinsand dibenzo/b,f/thiepin-3-carboxaldehydes as prostaglandinantagonists
YU143380A (en) Process for preparing 1,2-dichloroethane
YU298180A (en) Process for preparing 5,10-dihydroimidazo-2,1-quinazoline
DE3060850D1 (en) Process for preparing naphthalenesulphochloride
PT71056A (en) Process for preparing substituted 2-aminopirazines
PT70863B (en) Process for preparing de a-steroids
PT71055A (en) Process for preparing hydroxyimino-substituted aminoacetonitriles
YU63179A (en) Process for preparing 3-hydrazine-1,4-benzodiazepine-2-one derivatives
HU187262B (en) Process for preparing new tetrahydro-1,4-benzodiazepin-2-ones
DE3063194D1 (en) Process for preparing cyclopentenolones
PL116331B2 (en) Process for preparing 2,2,5,9-tetramethyldecadi-4,8-en-1-al